4.7 Article

CRISPR Start-Loss: A Novel and Practical Alternative for Gene Silencing through Base-Editing-Induced Start Codon Mutations

Journal

MOLECULAR THERAPY-NUCLEIC ACIDS
Volume 21, Issue -, Pages 1062-1073

Publisher

CELL PRESS
DOI: 10.1016/j.omtn.2020.07.037

Keywords

-

Funding

  1. National Key Research and Development Program of China Stem Cell and Translational Research [2019YFA0110700, 2017YFA0105101]
  2. Program for Changjiang Scholars and Innovative Research Team in University [IRT_16R32]
  3. Strategic Priority Research Program of the Chinese Academy of Sciences [XDA16030501, XDA16030503]
  4. Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104004]

Ask authors/readers for more resources

CRISPR-Cas9-mediated gene knockout and base-editing associated induction of STOP codons (iSTOP) have been widely used to exterminate the function of a coding gene, while they have been reported to exhibit side effects. In this study, we propose a novel and practical alternative method referred to as CRISPR Start-Loss (CRISPR-SL), which eliminates gene expression by utilizing both adenine base editors (ABEs) and cytidine base editors (CBEs) to disrupt the initiation codon (ATG). CRISPR-SL has been verified to be a feasible strategy on the cellular and embryonic levels (mean editing efficiencies up to 30.67% and 73.50%, respectively) and in two rabbit models mimicking Otc deficiency (Otc gene) and long hair economic traits (Fgf5 gene).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available